Factors associated with improvement in survival following heart attack

August 30, 2016

Among nearly 400,000 patients hospitalized with a certain type of heart attack in England and Wales between 2003 and 2013, improvement in survival was significantly associated with use of an invasive coronary strategy (such as coronary angiography) and not entirely related to a decline in baseline clinical risk or increased use of pharmacological therapies, according to a study published online by JAMA. The study is being released to coincide with its presentation at the European Society of Cardiology Congress 2016.

There has been a global decline in the rates of death following acute coronary syndrome (conditions such as heart attack or unstable angina); however, the extent to which this is due to use of guideline-indicated treatments for management of non-ST-elevation myocardial infarction (NSTEMI; a type of heart attack with certain findings on an electrocardiogram) is not known. Marlous Hall, Ph.D., of the University of Leeds, Leeds, England, and colleagues analyzed data on 389,057 patients with NSTEMI in 247 hospitals in England and Wales. Among these patients, there were 113,586 deaths (29 percent). From 2003-2004 to 2012-2013, proportions with intermediate to high clinical risk (patient factors such as cardiac arrest, elevated enzyme levels, systolic blood pressure, heart rate) decreased (87 percent vs 82 percent); proportions with lowest risk increased (4.2 percent vs 7.6 percent). The prevalence of diabetes, hypertension, cerebrovascular disease, chronic obstructive pulmonary disease, chronic renal failure, previous invasive coronary strategy, and current or ex-smoking status increased. Unadjusted all-cause mortality rates at 180 days decreased from 10.8 percent to 7.6 percent.

Analysis indicated that improvements in survival were associated with use of an invasive coronary strategy (defined as coronary angiography, percutaneous coronary intervention [procedure such as stent placement], coronary artery bypass graft surgery), which was associated with a relative decrease in mortality of 46 percent. A reduction in baseline acute coronary syndrome risk, increase in comorbidities, and use of guideline-indicated pharmacological therapies did not fully explain improvement in survival.

The authors note that these findings should not be interpreted to indicate that medical therapies have no role in management of NSTEMI. In this study group, aspirin, P2Y12 inhibitors, beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins each had a significant association with improved survival.
(doi:10.1001/jama.2016.10766; the study is available pre-embargo to the media at the For the Media website)

Editors Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.Note: Available pre-embargo at the For The Media website is an accompanying editorial, "Management of Non-ST-Elevation Myocardial Infarction," by Erin A. Bohula, M.D., D.Phil., and Elliott M. Antman, M.D., of Brigham and Women's Hospital, Harvard Medical School, Boston.

The JAMA Network Journals

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.